News

The EMA has published a final report about its pilot project on adaptive pathways. The results of the project showed that adaptive pathways can bring together regulators, HTA bodies, healthcare professionals and patients to agree on plans to generate data on a medicine in areas of unmet medical need.

Medidata announced that its cloud technology platform has been adopted by Israeli biotech, Pluristem Therapeutics.

In the shifting landscape of product development, the pharma and biotech arenas increasingly emphasize the need to use less internal R&D resources, increase efficiency, and reduce costs. One product development strategy is the utilization of lean outsourcing models for clinical studies.

Despite the increasing number of clinical trials in the United States, still participation remains at an all-time low. You can make a difference with participation in INC Research and CISCRP’s “Inspiring Hope’ Ideathon by submitting ideas to increase clinical research awareness.

OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States.

The Clinical Trials Transformation Initiative (CTTI) have released recommendations for hospital acquired and ventilator-associated bacterial pneumonia (HABP/VABP) as part of its antibacterial drug development program.

CRF Health has acquired Entra Health, an international digital health and IT solutions provider.

The KMR Group has completed its industry analysis on the comprehensive cost of clinical trials.

The uncertainty surrounding where the agency and its 890-member staff will call home next may linger for months, if not years.

Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.

More precision models in connecting patients to clinical trials and treatment options are vying to close the ever-elusive recruitment gap.

Survey delves deep into what constitutes true game-changing innovation in clinical development.

A proposed operational framework to support digital- and mHealth-based clinical trials in Africa.

Exploring the benefits from cross-company data sharing for study planning and investigator selection.

An examination of recent failures in Phase III studies and innovative approaches to reduce risk.

Research reveals a need for sponsors to be much more consistent, disciplined and focused in their CRO usage.

Study measures the differing judgment levels between clinical investigators and drug safety experts.